Statins
Also known as: HMG-CoA reductase inhibitors, cholesterol-lowering drugs
Medically reviewed by Nano Health Insights Editorial Team · Last reviewed 2026-06-24
Statins are HMG-CoA reductase inhibitors that lower LDL cholesterol and reduce heart attack and stroke risk.
What it is
Statins are HMG-CoA reductase inhibitors that lower LDL cholesterol and reduce heart attack and stroke risk. A key treatment threshold used in major guidelines is LDL-C 190 mg/dL or higher, where high-intensity statin therapy is often recommended unless there is a contraindication. Statins are among the most studied drug classes in cardiovascular medicine and are used both for primary prevention in people at elevated future risk and secondary prevention in people who already have atherosclerotic cardiovascular disease (ASCVD), such as prior heart attack, ischemic stroke, or peripheral artery disease.
These medicines are usually prescribed along with lifestyle measures such as diet, physical activity, weight management, and smoking cessation. They do not replace lifestyle change, but they can add substantial risk reduction when cholesterol is high or cardiovascular risk is significant.
Common statins include:
| Statin | Typical intensity role |
|---|---|
| Atorvastatin | Moderate to high intensity |
| Rosuvastatin | Moderate to high intensity |
| Simvastatin | Usually moderate intensity |
| Pravastatin | Low to moderate intensity |
| Lovastatin | Low to moderate intensity |
| Fluvastatin | Low to moderate intensity |
| Pitavastatin | Moderate intensity |
In India, statins are widely used for dyslipidemia, diabetes-related cardiovascular risk, and established coronary artery disease. Exact drug choice often depends on LDL level, overall risk, liver history, kidney function, cost, and possible interactions with other medicines.
How it works
Statins block the liver enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase, which is involved in cholesterol synthesis. When this pathway is inhibited, the liver increases the number of LDL receptors on its surface and removes more LDL cholesterol from the blood.
The main effect is a reduction in LDL-C, but statins can also modestly lower triglycerides and slightly raise HDL-C. Their benefit is not only from changing cholesterol numbers. Statins also appear to improve plaque stability and reduce vascular inflammation, which helps explain why they lower the risk of heart attack and ischemic stroke.
Clinicians often group statins by intensity because the expected LDL reduction matters in treatment decisions:
- High-intensity: usually lowers LDL-C by about 50% or more.
- Moderate-intensity: usually lowers LDL-C by about 30% to 49%.
- Low-intensity: usually lowers LDL-C by less than 30%.
Atorvastatin and rosuvastatin are the statins most commonly used when a large LDL reduction is needed.
Evidence and uses
Evidence for statins is strong in people with established ASCVD and in many people at elevated risk who have not yet had an event. Major guideline-based use cases include:
- Secondary prevention: after heart attack, ischemic stroke, angina, coronary stenting, bypass surgery, or peripheral artery disease.
- Primary prevention with very high LDL-C: especially LDL-C 190 mg/dL or higher.
- Diabetes in many adults aged 40 to 75 years: depending on overall cardiovascular risk.
- Primary prevention based on estimated risk: when age, blood pressure, smoking, diabetes, and cholesterol together suggest meaningful future ASCVD risk.
Statins do not help every person to the same degree. Absolute benefit depends on baseline risk. Someone who already has coronary artery disease usually gains more absolute risk reduction than someone with only mildly elevated cholesterol and otherwise low risk.
They are also used in some inherited lipid disorders, including familial hypercholesterolemia, though additional drugs may be needed if LDL remains high.
A practical comparison is:
| Situation | Role of statins |
|---|---|
| Prior heart attack or stroke | Standard therapy unless contraindicated |
| LDL-C ≥190 mg/dL | Often high-intensity treatment |
| Diabetes age 40-75 | Often indicated, intensity varies by risk |
| Low short-term risk and modest LDL elevation | May or may not be needed |
If there is uncertainty in primary prevention, clinicians may use a risk calculator and sometimes coronary artery calcium scoring to refine the decision.
Safety and interactions
Most people tolerate statins well, but side effects and interactions matter.
Common or important adverse effects include:
- Muscle aches or weakness
- Mild increases in liver enzymes
- Rare severe muscle injury such as rhabdomyolysis
- Small increase in blood glucose or diabetes risk in some people
- Digestive symptoms in some users
Muscle symptoms are one of the most common reasons people stop treatment, but not all muscle pain during statin use is caused by the drug. A clinician may check for other causes, review interacting medicines, lower the dose, switch to a different statin, or try alternate dosing in selected cases.
Important interactions can raise statin levels and side-effect risk. These include some macrolide antibiotics, azole antifungals, certain HIV medicines, cyclosporine, and some heart medicines. Grapefruit juice can interact with particular statins, especially simvastatin, lovastatin, and to a lesser extent atorvastatin. Risk also rises when statins are combined with some other lipid-lowering drugs, especially fibrates such as gemfibrozil.
Statins are generally avoided during pregnancy. People with active liver disease need careful assessment before use. Kidney disease may affect statin choice or dose.
Do not start, stop, or split doses on your own. If you develop unexplained muscle pain, dark urine, marked fatigue, jaundice, or severe weakness, contact a clinician promptly. A pharmacist can also help review interaction risks, including over-the-counter products and supplements.
When to see a clinician
See a clinician if you have high cholesterol, diabetes, high blood pressure, a strong family history of early heart disease, or a prior cardiovascular event. You should also seek review if you were prescribed a statin but are unsure why, have stopped it because of side effects, or want to know whether your current dose is appropriate.
People taking statins should have periodic follow-up to review:
- Lipid results and treatment response
- Side effects or muscle symptoms
- Liver history and other medical conditions
- New medicines that may interact
- Adherence and lifestyle measures
In India, this is especially relevant because cardiovascular disease often occurs at younger ages than expected, and diabetes is common. A clinician may consider overall risk rather than cholesterol alone.
Limitations and open questions
Statins are highly effective, but they are not a cure for all cardiovascular risk. Some people still have events despite good LDL lowering, which is why blood pressure control, diabetes care, smoking cessation, sleep, diet, and exercise remain important.
Evidence is strongest for prevention of ASCVD events, not for every possible proposed benefit. Research continues on how best to personalize statin intensity, how to manage statin intolerance, and which patients benefit most from adding non-statin drugs such as ezetimibe or PCSK9 inhibitors.
There is also ongoing discussion about the balance of benefit and harm in lower-risk primary prevention groups. In these situations, shared decision-making matters. Evidence in humans is strong for cardiovascular prevention, but the best threshold for starting treatment can vary by age, baseline risk, comorbidities, and patient preference.
A final practical point is that response differs between individuals. If LDL does not fall as expected, the reason may be adherence, diet, genetics, absorption, or an interacting medicine. That is why follow-up lipid testing after starting or changing a statin is part of good care.
FAQs
What are statins mainly used for?
Statins are mainly used to lower LDL cholesterol and reduce the risk of heart attack and ischemic stroke. They are used both for people who already have atherosclerotic cardiovascular disease and for some people who have not had an event but have high LDL or elevated overall risk. A common guideline trigger is LDL-C 190 mg/dL or higher.
Which statins are considered strongest?
Atorvastatin and rosuvastatin are the statins most often used when a large LDL reduction is needed. At higher doses, they are considered high-intensity therapy and can lower LDL-C by about 50% or more. The exact choice depends on kidney function, interactions, side effects, and treatment goals.
Do statins cause muscle pain?
They can, but not every muscle ache during treatment is caused by the statin. Muscle symptoms are a common reason for stopping therapy, while severe muscle injury such as rhabdomyolysis is rare. If symptoms occur, a clinician may review other causes, check for drug interactions, and consider changing the statin or dose.
Do I need blood tests while taking a statin?
Usually yes. A lipid profile is commonly checked before treatment and again after starting or changing the dose to confirm that LDL has fallen as expected. Liver tests may be checked at baseline or if symptoms suggest a problem, but routine repeated liver testing is not needed for everyone.
Can I take statins with other medicines or supplements?
Sometimes, but interactions are important. Certain antibiotics, antifungals, HIV medicines, cyclosporine, grapefruit juice, and some fibrates can increase statin levels and side-effect risk. Tell your clinician or pharmacist about all prescription drugs, over-the-counter medicines, and supplements before starting a statin.